Cargando…
Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma
BACKGROUND: The identification of differentially expressed tumor-associated proteins and genomic alterations driving neoplasia is critical in the development of clinical assays to detect cancers and forms the foundation for understanding cancer biology. One of the challenges in the analysis of pancr...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583468/ https://www.ncbi.nlm.nih.gov/pubmed/36266629 http://dx.doi.org/10.1186/s12014-022-09373-x |
_version_ | 1784813078064398336 |
---|---|
author | Li, Qing Kay Hu, Yingwei Chen, Lijun Schnaubelt, Michael Cui Zhou, Daniel Li, Yize Lu, Rita Jui-Hsien Thiagarajan, Mathangi Hostetter, Galen Newton, Chelsea J. Jewell, Scott D. Omenn, Gil Robles, Ana I. Mesri, Mehdi Bathe, Oliver F. Zhang, Bing Ding, Li Hruban, Ralph H. Chan, Daniel W. Zhang, Hui |
author_facet | Li, Qing Kay Hu, Yingwei Chen, Lijun Schnaubelt, Michael Cui Zhou, Daniel Li, Yize Lu, Rita Jui-Hsien Thiagarajan, Mathangi Hostetter, Galen Newton, Chelsea J. Jewell, Scott D. Omenn, Gil Robles, Ana I. Mesri, Mehdi Bathe, Oliver F. Zhang, Bing Ding, Li Hruban, Ralph H. Chan, Daniel W. Zhang, Hui |
author_sort | Li, Qing Kay |
collection | PubMed |
description | BACKGROUND: The identification of differentially expressed tumor-associated proteins and genomic alterations driving neoplasia is critical in the development of clinical assays to detect cancers and forms the foundation for understanding cancer biology. One of the challenges in the analysis of pancreatic ductal adenocarcinoma (PDAC) is the low neoplastic cellularity and heterogeneous composition of bulk tumors. To enrich neoplastic cells from bulk tumor tissue, coring, and laser microdissection (LMD) sampling techniques have been employed. In this study, we assessed the protein and KRAS mutation changes associated with samples obtained by these enrichment techniques and evaluated the fraction of neoplastic cells in PDAC for proteomic and genomic analyses. METHODS: Three fresh frozen PDAC tumors and their tumor-matched normal adjacent tissues (NATs) were obtained from three sampling techniques using bulk, coring, and LMD; and analyzed by TMT-based quantitative proteomics. The protein profiles and characterizations of differentially expressed proteins in three sampling groups were determined. These three PDACs and samples of five additional PDACs obtained by the same three sampling techniques were also subjected to genomic analysis to characterize KRAS mutations. RESULTS: The neoplastic cellularity of eight PDACs ranged from less than 10% to over 80% based on morphological review. Distinctive proteomic patterns and abundances of certain tumor-associated proteins were revealed when comparing the tumors and NATs by different sampling techniques. Coring and bulk tissues had comparable proteome profiles, while LMD samples had the most distinct proteome composition compared to bulk tissues. Further genomic analysis of bulk, cored, or LMD samples demonstrated that KRAS mutations were significantly enriched in LMD samples while coring was less effective in enriching for KRAS mutations when bulk tissues contained a relatively low neoplastic cellularity. CONCLUSIONS: In addition to bulk tissues, samples from LMD and coring techniques can be used for proteogenomic studies. The greatest enrichment of neoplastic cellularity is obtained with the LMD technique. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12014-022-09373-x. |
format | Online Article Text |
id | pubmed-9583468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95834682022-10-21 Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma Li, Qing Kay Hu, Yingwei Chen, Lijun Schnaubelt, Michael Cui Zhou, Daniel Li, Yize Lu, Rita Jui-Hsien Thiagarajan, Mathangi Hostetter, Galen Newton, Chelsea J. Jewell, Scott D. Omenn, Gil Robles, Ana I. Mesri, Mehdi Bathe, Oliver F. Zhang, Bing Ding, Li Hruban, Ralph H. Chan, Daniel W. Zhang, Hui Clin Proteomics Research BACKGROUND: The identification of differentially expressed tumor-associated proteins and genomic alterations driving neoplasia is critical in the development of clinical assays to detect cancers and forms the foundation for understanding cancer biology. One of the challenges in the analysis of pancreatic ductal adenocarcinoma (PDAC) is the low neoplastic cellularity and heterogeneous composition of bulk tumors. To enrich neoplastic cells from bulk tumor tissue, coring, and laser microdissection (LMD) sampling techniques have been employed. In this study, we assessed the protein and KRAS mutation changes associated with samples obtained by these enrichment techniques and evaluated the fraction of neoplastic cells in PDAC for proteomic and genomic analyses. METHODS: Three fresh frozen PDAC tumors and their tumor-matched normal adjacent tissues (NATs) were obtained from three sampling techniques using bulk, coring, and LMD; and analyzed by TMT-based quantitative proteomics. The protein profiles and characterizations of differentially expressed proteins in three sampling groups were determined. These three PDACs and samples of five additional PDACs obtained by the same three sampling techniques were also subjected to genomic analysis to characterize KRAS mutations. RESULTS: The neoplastic cellularity of eight PDACs ranged from less than 10% to over 80% based on morphological review. Distinctive proteomic patterns and abundances of certain tumor-associated proteins were revealed when comparing the tumors and NATs by different sampling techniques. Coring and bulk tissues had comparable proteome profiles, while LMD samples had the most distinct proteome composition compared to bulk tissues. Further genomic analysis of bulk, cored, or LMD samples demonstrated that KRAS mutations were significantly enriched in LMD samples while coring was less effective in enriching for KRAS mutations when bulk tissues contained a relatively low neoplastic cellularity. CONCLUSIONS: In addition to bulk tissues, samples from LMD and coring techniques can be used for proteogenomic studies. The greatest enrichment of neoplastic cellularity is obtained with the LMD technique. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12014-022-09373-x. BioMed Central 2022-10-20 /pmc/articles/PMC9583468/ /pubmed/36266629 http://dx.doi.org/10.1186/s12014-022-09373-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Li, Qing Kay Hu, Yingwei Chen, Lijun Schnaubelt, Michael Cui Zhou, Daniel Li, Yize Lu, Rita Jui-Hsien Thiagarajan, Mathangi Hostetter, Galen Newton, Chelsea J. Jewell, Scott D. Omenn, Gil Robles, Ana I. Mesri, Mehdi Bathe, Oliver F. Zhang, Bing Ding, Li Hruban, Ralph H. Chan, Daniel W. Zhang, Hui Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma |
title | Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma |
title_full | Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma |
title_fullStr | Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma |
title_full_unstemmed | Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma |
title_short | Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma |
title_sort | neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583468/ https://www.ncbi.nlm.nih.gov/pubmed/36266629 http://dx.doi.org/10.1186/s12014-022-09373-x |
work_keys_str_mv | AT liqingkay neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT huyingwei neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT chenlijun neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT schnaubeltmichael neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT cuizhoudaniel neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT liyize neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT luritajuihsien neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT thiagarajanmathangi neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT hostettergalen neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT newtonchelseaj neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT jewellscottd neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT omenngil neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT roblesanai neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT mesrimehdi neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT batheoliverf neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT zhangbing neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT dingli neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT hrubanralphh neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT chandanielw neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma AT zhanghui neoplasticcellenrichmentoftumortissuesusingcoringandlasermicrodissectionforproteomicandgenomicanalysesofpancreaticductaladenocarcinoma |